PAM
PVG Asset Management Portfolio holdings
AUM
$29.4M
This Quarter Return
+5.01%
1 Year Return
+17.61%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$22.6M
AUM Growth
+$22.6M
(-13%)
Cap. Flow
-$4.92M
Cap. Flow
% of AUM
-21.75%
Top 10 Holdings %
Top 10 Hldgs %
69.92%
Holding
55
New
18
Increased
4
Reduced
10
Closed
19
Top Buys
| 1 |
SPDR SSGA Ultra Short Term Bond ETF
ULST
|
$2.82M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$2.39M |
| 3 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
$698K |
| 4 |
iShares S&P 500 Growth ETF
IVW
|
$634K |
| 5 |
ProShares UltraShort Russell2000
TWM
|
$621K |
Top Sells
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
$3.74M |
| 2 |
Direxion Daily S&P 500 Bear 1X Shares
SPDN
|
$3.13M |
| 3 |
ProShares UltraShort S&P500
SDS
|
$1.51M |
| 4 |
ProShares Short Russell2000
RWM
|
$1.22M |
| 5 |
ProShares Short S&P500
SH
|
$876K |
Sector Composition
| 1 | Financials | 5.23% |
| 2 | Industrials | 3.52% |
| 3 | Healthcare | 3.37% |
| 4 | Materials | 2.58% |
| 5 | Communication Services | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sarepta Therapeutics
SRPT
$1.98B
| – | – |
-3,123
| Closed | -$345K |
|
52
Viking Therapeutics
VKTX
$3.02B
| – | – |
-14,810
| Closed | -$40.3K |
|
53
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$1.86B
| – | – |
-5,863
| Closed | -$731K |
|
|
RNTX
54
Rein Therapeutics, Inc. Common Stock
RNTX
$29M
| – | – |
-5,880
| Closed | -$24.3K |
|